Tag: Edwards Lifesciences

In “Innovation Momentum 2024: The Global Top 100” LexisNexis uncovers which companies, industries and regions are driving innovation forward NEW YORK, February 21, 2024 – Select companies in the pharmaceutical, semiconductor and information technology industries are pushing innovation at a […]

Comprehensive economic analysis finds no need to halt sales of device at center of patent dispute   Edwards Lifesciences thwarted a competitor’s bid for a significant temporary restraining order and preliminary injunction against its innovative PASCAL heart device after Intensity and attorneys at Paul, Weiss, Rifkind & Garrison LLP presented a comprehensive analysis refuting arguments for halting sales of […]